RR

Rahul Reddy

Active Director Director DIN 10487071
DIN 10487071 First appointment Feb 2024 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Rahul Reddy

Data last updated:

Rahul Reddy is a Director at Nutech Biosciences India Private Limited (since 2024). The company operates in Agriculture. Nutech Biosciences India Private Limited reported revenue of ₹17.35 Cr (FY 2025).

DIN 10487071
Primary Designation Director
Industry Agriculture
First Appointment 01 Feb 2024
Oldest Company Age 11 yrs
Largest company Nutech Biosciences India Private Limited · ₹17.35 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20242015₹17.35 Cr (FY 2025)Active

Board colleagues of Rahul Reddy

Directorship timeline

Open interactive timeline →
Nutech Biosciences India Private Limited
Premium access

Shareholding and investment profile for Rahul Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Reddy

Rahul Reddy currently holds 1 directorship: Nutech Biosciences India Private Limited (Director, since 01 Feb 2024, revenue ₹17.35 Cr (FY 2025)).

Rahul Reddy was first appointed on 01 Feb 2024 as Director at Nutech Biosciences India Private Limited.

The current boards of Rahul Reddy's companies include Deepika Reddy (Nutech Biosciences India Private Limited), Sada Siva Reddy Narahari (Nutech Biosciences India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available